Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database

(1) Background: The purpose of study was to compare the safety profile of glatiramer with natalizumab, alemtuzumab and ocrelizumab in pregnant and lactating women affected by multiple sclerosis (MS). (2) Methods: Individual case safety reports (ICSRs) were retrieved from the European spontaneous rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Sportiello, Liberata, Di Napoli, Raffaella, Balzano, Nunzia, Mascolo, Annamaria, Ruggiero, Rosanna, Di Costanzo, Luigi, Monaco, Davida, Maniscalco, Giorgia Teresa, Capuano, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675378/
https://www.ncbi.nlm.nih.gov/pubmed/38004432
http://dx.doi.org/10.3390/ph16111566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675378/
https://www.ncbi.nlm.nih.gov/pubmed/38004432
http://dx.doi.org/10.3390/ph16111566

Ejemplares similares